TAK1 is a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma
Anh Tuan Vuong, Aniket S. Joshi, Anirban Roy, Kavya Mathukumalli, Phuong T. Ho, Raksha R. Bhat, Meiricris Tomaz da Silva, Tagari Samanta, Meghana V. Trivedi, Bin Guo, Benny Abraham Kaipparettu, Ashok Kumar
This study identifies TAK1 as a key regulator of oncogenic signaling and differentiation blockade in rhabdomyosarcoma, showing its role in promoting proliferation and inhibiting myogenic differentiation.
Oncogene · Apr 6, 2026Peer-reviewedCancer Biology